Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Depreciation and Depletion (2016 - 2025)

BioCorRx's Depreciation and Depletion history spans 13 years, with the latest figure at $1474.0 for Q3 2025.

  • For Q3 2025, Depreciation and Depletion fell 77.04% year-over-year to $1474.0; the TTM value through Sep 2025 reached $22076.0, down 14.03%, while the annual FY2024 figure was $31966.0, 24.73% up from the prior year.
  • Depreciation and Depletion for Q3 2025 was $1474.0 at BioCorRx, down from $4130.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $12708.0 in Q4 2024 and bottomed at $1474.0 in Q3 2025.
  • The 5-year median for Depreciation and Depletion is $6420.0 (2023), against an average of $6369.1.
  • The largest annual shift saw Depreciation and Depletion soared 97.94% in 2024 before it crashed 77.04% in 2025.
  • A 5-year view of Depreciation and Depletion shows it stood at $6567.0 in 2021, then changed by 0.0% to $6567.0 in 2022, then fell by 2.24% to $6420.0 in 2023, then skyrocketed by 97.94% to $12708.0 in 2024, then tumbled by 88.4% to $1474.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Depreciation and Depletion are $1474.0 (Q3 2025), $4130.0 (Q2 2025), and $3764.0 (Q1 2025).